IRIS Accounts Production v24.2.0.383 14614698 director 24.1.23 31.3.24 31.3.24 false true false false false true false Ordinary A 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh146146982023-01-23146146982024-03-31146146982023-01-242024-03-31146146982023-01-2314614698ns15:EnglandWales2023-01-242024-03-3114614698ns14:PoundSterling2023-01-242024-03-3114614698ns10:Director12023-01-242024-03-3114614698ns10:PrivateLimitedCompanyLtd2023-01-242024-03-3114614698ns10:SmallEntities2023-01-242024-03-3114614698ns10:AuditExempt-NoAccountantsReport2023-01-242024-03-3114614698ns10:SmallCompaniesRegimeForDirectorsReport2023-01-242024-03-3114614698ns10:SmallCompaniesRegimeForAccounts2023-01-242024-03-3114614698ns10:AbridgedAccounts2023-01-242024-03-311461469812023-01-242024-03-3114614698ns10:OrdinaryShareClass12023-01-242024-03-3114614698ns10:RegisteredOffice2023-01-242024-03-3114614698ns5:CurrentFinancialInstruments2024-03-3114614698ns5:ShareCapital2024-03-3114614698ns5:RetainedEarningsAccumulatedLosses2024-03-3114614698ns5:NetGoodwill2023-01-242024-03-3114614698ns5:FurnitureFittings2023-01-242024-03-3114614698ns5:DeferredTaxation2023-01-242024-03-3114614698ns5:DeferredTaxation2024-03-3114614698ns10:OrdinaryShareClass12024-03-3114614698ns5:RetainedEarningsAccumulatedLosses2023-01-242024-03-31
REGISTERED NUMBER: 14614698 (England and Wales)



















Unaudited Financial Statements

for the Period

24 January 2023 to 31 March 2024

for

FIROZ HEALTHCARE LIMITED

FIROZ HEALTHCARE LIMITED (REGISTERED NUMBER: 14614698)






Contents of the Financial Statements
for the Period 24 January 2023 to 31 March 2024




Page

Company Information 1

Abridged Statement of Financial Position 2

Notes to the Financial Statements 4


FIROZ HEALTHCARE LIMITED

Company Information
for the Period 24 January 2023 to 31 March 2024







DIRECTOR: Nazam Ali Din





REGISTERED OFFICE: 5a Suffrage Street
Smethwick
Birmingham
West Midlands
B66 3PZ





REGISTERED NUMBER: 14614698 (England and Wales)





ACCOUNTANTS: Brindleys Limited
2 Wheeleys Road
Edgbaston
Birmingham
West Midlands
B15 2LD

FIROZ HEALTHCARE LIMITED (REGISTERED NUMBER: 14614698)

Abridged Statement of Financial Position
31 March 2024

Notes £    £   
FIXED ASSETS
Intangible assets 4 722,332
Tangible assets 5 22,640
744,972

CURRENT ASSETS
Stocks 55,968
Debtors 101,265
Cash at bank and in hand 37,804
195,037
CREDITORS
Amounts falling due within one year 997,474
NET CURRENT LIABILITIES (802,437 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(57,465

)

PROVISIONS FOR LIABILITIES 6 5,660
NET LIABILITIES (63,125 )

CAPITAL AND RESERVES
Called up share capital 7 1
Retained earnings 8 (63,126 )
SHAREHOLDERS' FUNDS (63,125 )

FIROZ HEALTHCARE LIMITED (REGISTERED NUMBER: 14614698)

Abridged Statement of Financial Position - continued
31 March 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Financial Position for the period ended 31 March 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 September 2024 and were signed by:





Nazam Ali Din - Director


FIROZ HEALTHCARE LIMITED (REGISTERED NUMBER: 14614698)

Notes to the Financial Statements
for the Period 24 January 2023 to 31 March 2024

1. STATUTORY INFORMATION

Firoz Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2023, is being amortised evenly over its estimated useful life of twenty years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

FIROZ HEALTHCARE LIMITED (REGISTERED NUMBER: 14614698)

Notes to the Financial Statements - continued
for the Period 24 January 2023 to 31 March 2024

2. ACCOUNTING POLICIES - continued

Holiday pay
Holiday pay is recognised as an expense in the in which the service is received.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 5 .

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
Additions 760,349
At 31 March 2024 760,349
AMORTISATION
Amortisation for period 38,017
At 31 March 2024 38,017
NET BOOK VALUE

At 31 March 2024 722,332

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
Additions 26,635
At 31 March 2024 26,635
DEPRECIATION
Charge for period 3,995
At 31 March 2024 3,995
NET BOOK VALUE
At 31 March 2024 22,640

6. PROVISIONS FOR LIABILITIES
£   
Deferred tax 5,660

FIROZ HEALTHCARE LIMITED (REGISTERED NUMBER: 14614698)

Notes to the Financial Statements - continued
for the Period 24 January 2023 to 31 March 2024

6. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Provided during period 5,660
Balance at 31 March 2024 5,660

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
1 Ordinary A 1 1

8. RESERVES
Retained
earnings
£   

Deficit for the period (63,126 )
At 31 March 2024 (63,126 )